Natixis Advisors LLC Sells 4,347 Shares of Encompass Health Co. (NYSE:EHC)

Natixis Advisors LLC decreased its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 4.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 96,949 shares of the company's stock after selling 4,347 shares during the quarter. Natixis Advisors LLC owned 0.10% of Encompass Health worth $8,953,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. MassMutual Private Wealth & Trust FSB lifted its stake in Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after buying an additional 137 shares in the last quarter. Avior Wealth Management LLC acquired a new stake in shares of Encompass Health during the third quarter valued at approximately $40,000. Tompkins Financial Corp purchased a new stake in shares of Encompass Health in the 4th quarter valued at approximately $46,000. V Square Quantitative Management LLC boosted its stake in Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after purchasing an additional 177 shares during the period. Finally, Morse Asset Management Inc purchased a new position in Encompass Health during the 3rd quarter worth approximately $68,000. Institutional investors own 97.25% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently commented on EHC shares. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $110.00 target price on shares of Encompass Health in a research report on Tuesday, February 11th. Barclays raised their price objective on Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research report on Friday, February 7th. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. KeyCorp raised their price target on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Finally, William Blair reiterated an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Ten research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Encompass Health has an average rating of "Buy" and an average target price of $107.67.

Remove Ads

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.10% of the stock is owned by corporate insiders.

Encompass Health Stock Up 0.8 %

Shares of Encompass Health stock traded up $0.75 during midday trading on Tuesday, reaching $100.71. 640,230 shares of the company's stock traded hands, compared to its average volume of 632,656. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. Encompass Health Co. has a 52 week low of $76.11 and a 52 week high of $104.55. The company's 50 day simple moving average is $98.13 and its 200 day simple moving average is $97.20. The company has a market cap of $10.14 billion, a price-to-earnings ratio of 22.58, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Equities analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio is 15.25%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.